Viewing Study NCT00859105


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2025-12-26 @ 1:55 AM
Study NCT ID: NCT00859105
Status: COMPLETED
Last Update Posted: 2009-03-10
First Post: 2009-03-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
Sponsor: Apotex Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module